Schrödinger Past Earnings Performance
Past criteria checks 0/6
Schrödinger's earnings have been declining at an average annual rate of -20%, while the Healthcare Services industry saw earnings growing at 23.3% annually. Revenues have been growing at an average rate of 19.2% per year.
Key information
-20.0%
Earnings growth rate
12.4%
EPS growth rate
Healthcare Services Industry Growth | 1.7% |
Revenue growth rate | 19.2% |
Return on equity | -39.5% |
Net Margin | -91.8% |
Next Earnings Update | 26 Feb 2025 |
Recent past performance updates
Recent updates
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 25% Higher
Jan 25Companies Like Schrödinger (NASDAQ:SDGR) Are In A Position To Invest In Growth
Jan 06Schrödinger: Positive Signs Despite The Share Price Decline
Nov 21Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 26% Higher
Nov 13Schrödinger's Path Forward: AI, Cash Burn, And Clinical Uncertainty
Oct 17Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues
Sep 27Schrodinger: More Drug Discovery Validation
Aug 06Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation
Aug 05We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right
Jun 12Schrödinger: More Pharmaceutical Than Software
May 07Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar
May 02Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially
Mar 01Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024
Mar 01Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?
Feb 28The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%
Feb 01Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable
Dec 18Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?
Sep 28Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?
Jul 01Schrödinger: Q2 Earnings Supports Growth Narrative
Aug 26Schrödinger appoints Dr. Geoffrey Porges as finance chief
Aug 18Sizing Up Schrodinger
Jun 06Schrödinger: Holding The Keys To Discovery
Mar 26Schrodinger: A Long-Term Hold For Biotech Investors With Upside Potential Too
Mar 15Revenue & Expenses Breakdown
How Schrödinger makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 193 | -178 | 140 | 204 |
30 Jun 24 | 201 | -201 | 138 | 200 |
31 Mar 24 | 188 | -143 | 137 | 192 |
31 Dec 23 | 217 | 41 | 136 | 182 |
30 Sep 23 | 199 | 44 | 133 | 165 |
30 Jun 23 | 194 | 66 | 131 | 151 |
31 Mar 23 | 197 | 14 | 128 | 139 |
31 Dec 22 | 181 | -149 | 121 | 126 |
30 Sep 22 | 170 | -153 | 112 | 117 |
30 Jun 22 | 163 | -148 | 105 | 107 |
31 Mar 22 | 154 | -135 | 96 | 97 |
31 Dec 21 | 138 | -100 | 86 | 91 |
30 Sep 21 | 125 | -81 | 81 | 83 |
30 Jun 21 | 121 | -42 | 72 | 77 |
31 Mar 21 | 114 | -11 | 65 | 72 |
31 Dec 20 | 108 | -24 | 60 | 65 |
30 Sep 20 | 101 | -20 | 54 | 58 |
30 Jun 20 | 95 | -35 | 52 | 52 |
31 Mar 20 | 91 | -33 | 52 | 45 |
31 Dec 19 | 86 | -25 | 48 | 39 |
30 Sep 19 | 77 | -24 | 46 | 37 |
30 Jun 19 | 70 | -24 | 43 | 36 |
31 Mar 19 | 69 | -29 | 38 | 35 |
31 Dec 18 | 67 | -28 | 36 | 35 |
31 Dec 17 | 56 | -17 | 31 | 28 |
Quality Earnings: SDGR is currently unprofitable.
Growing Profit Margin: SDGR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SDGR is unprofitable, and losses have increased over the past 5 years at a rate of 20% per year.
Accelerating Growth: Unable to compare SDGR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SDGR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.5%).
Return on Equity
High ROE: SDGR has a negative Return on Equity (-39.51%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 06:37 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Schrödinger, Inc. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Gaurav Goparaju | Berenberg |
Clarence Powell | BMO Capital Markets Equity Research |
Evan Seigerman | BMO Capital Markets Equity Research |